GSA CAPITAL PARTNERS LLP - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 65 filers reported holding PROQR THRAPEUTICS N V in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$96
+35.2%
74,084
+69.0%
0.01%
+14.3%
Q2 2023$71
-11.2%
43,836
+103.8%
0.01%
-30.0%
Q4 2022$80
-100.0%
21,514
-84.3%
0.01%
-91.5%
Q3 2021$1,147,000
+177.7%
137,003
+123.5%
0.12%
+154.3%
Q2 2021$413,000
+138.7%
61,289
+134.4%
0.05%
+58.6%
Q1 2021$173,000
-13.5%
26,152
-45.1%
0.03%
-12.1%
Q4 2020$200,000
+207.7%
47,625
+324.0%
0.03%
+266.7%
Q3 2019$65,00011,2310.01%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q1 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders